Revolution Medicines
Executive Director, Biostatistics Oncology
Revolution Medicines, San Francisco, California, United States, 94199
Overview
Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding Revolutionaries in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity:
We are seeking an experienced and dynamic Executive Director of Biostatistics to lead our oncology programs. This pivotal role involves providing strategic and technical leadership in the design and execution of statistical strategies, study designs, analyses, and regulatory submissions for late-phase oncology clinical trials. The successful candidate will be instrumental in building and enabling a high-performing biostatistics team dedicated to advancing our oncology pipeline. This role will report directly to the Vice President, Biostatistics. Responsibilities
Lead a biostatistics team for late-phase oncology programs, ensuring alignment with clinical development goals and regulatory requirements. Lead biostatistical strategy development for pivotal phase II/III trials, including adaptive designs and registration enabling trials. Partner closely with other subfunctions within quantitative sciences and with cross-functional teams, including clinical development, statistical programming, and regulatory affairs, to integrate statistical considerations into clinical development plans. Build, lead, and mentor a high-performing team of biostatisticians specializing in late-phase oncology development. Lead biostatistical activities for regulatory submissions. Develop and implement policies, standards, and procedures to ensure consistency and quality in statistical practices. Manage relationships with external partners, such as contract research organizations (CROs), ensuring adherence to timelines, budgets, and quality standards. Qualifications
Ph.D. or M.S. in Statistics/Biostatistics, extensive industry experience as a statistician (at least 15 years for Ph.D. holders and 17 years for M.S. holders), with at least 8 years in a leadership role within late-phase oncology biostatistics. Successful direct experience with FDA, EMA and PMDA interactions including regulatory meetings and responses to agency questions. Proven track record with successful regulatory submissions (NDA/MAA/J-DNA) to FDA, EMA, and PMDA. Proven ability to influence cross-functional teams, drive strategic initiatives, and mentor statistical talent. Solid knowledge of ICH and other regulatory requirements related to biostatistical activities and clinical trials. Strong communication skills with ability to present complex statistical concepts to diverse audiences. Excellent interpersonal and project management skills. Proficiency in SAS and/or R. Compensation and Benefits
The base pay salary range for this full-time position for candidates working onsite at our headquarters in Redwood City, CA is listed below. The range displayed is the base pay salary range for an individual working onsite in Redwood City and will be adjusted for the local market where the candidate is based. Individual base pay salary is determined by role, level, and location, and factors including job-related skills, experience, market dynamics, and relevant education or training. Please note that base pay salary range is one part of the overall total rewards program at Revolution Medicines, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities. Base Pay Salary Range $256,000 — $320,000 USD Location
Redwood City, CA Equity, Benefits, and EEO
Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status. We protect personal data in accordance with our CCPA Notice and Privacy Policy. Revolution Medicines takes protection and security of personal data seriously and respects your right to privacy while using our website and when contacting us by email or phone. For additional information, please contact privacy@revmed.com.
#J-18808-Ljbffr
Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding Revolutionaries in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity:
We are seeking an experienced and dynamic Executive Director of Biostatistics to lead our oncology programs. This pivotal role involves providing strategic and technical leadership in the design and execution of statistical strategies, study designs, analyses, and regulatory submissions for late-phase oncology clinical trials. The successful candidate will be instrumental in building and enabling a high-performing biostatistics team dedicated to advancing our oncology pipeline. This role will report directly to the Vice President, Biostatistics. Responsibilities
Lead a biostatistics team for late-phase oncology programs, ensuring alignment with clinical development goals and regulatory requirements. Lead biostatistical strategy development for pivotal phase II/III trials, including adaptive designs and registration enabling trials. Partner closely with other subfunctions within quantitative sciences and with cross-functional teams, including clinical development, statistical programming, and regulatory affairs, to integrate statistical considerations into clinical development plans. Build, lead, and mentor a high-performing team of biostatisticians specializing in late-phase oncology development. Lead biostatistical activities for regulatory submissions. Develop and implement policies, standards, and procedures to ensure consistency and quality in statistical practices. Manage relationships with external partners, such as contract research organizations (CROs), ensuring adherence to timelines, budgets, and quality standards. Qualifications
Ph.D. or M.S. in Statistics/Biostatistics, extensive industry experience as a statistician (at least 15 years for Ph.D. holders and 17 years for M.S. holders), with at least 8 years in a leadership role within late-phase oncology biostatistics. Successful direct experience with FDA, EMA and PMDA interactions including regulatory meetings and responses to agency questions. Proven track record with successful regulatory submissions (NDA/MAA/J-DNA) to FDA, EMA, and PMDA. Proven ability to influence cross-functional teams, drive strategic initiatives, and mentor statistical talent. Solid knowledge of ICH and other regulatory requirements related to biostatistical activities and clinical trials. Strong communication skills with ability to present complex statistical concepts to diverse audiences. Excellent interpersonal and project management skills. Proficiency in SAS and/or R. Compensation and Benefits
The base pay salary range for this full-time position for candidates working onsite at our headquarters in Redwood City, CA is listed below. The range displayed is the base pay salary range for an individual working onsite in Redwood City and will be adjusted for the local market where the candidate is based. Individual base pay salary is determined by role, level, and location, and factors including job-related skills, experience, market dynamics, and relevant education or training. Please note that base pay salary range is one part of the overall total rewards program at Revolution Medicines, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities. Base Pay Salary Range $256,000 — $320,000 USD Location
Redwood City, CA Equity, Benefits, and EEO
Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status. We protect personal data in accordance with our CCPA Notice and Privacy Policy. Revolution Medicines takes protection and security of personal data seriously and respects your right to privacy while using our website and when contacting us by email or phone. For additional information, please contact privacy@revmed.com.
#J-18808-Ljbffr